Meteora Capital x NKGen BiotechNKGen Biotech, Inc. • February 12th, 2024 • Biological products, (no disgnostic substances)
This binding term sheet (the “Term Sheet”) amends and restates the binding term sheet, dated as of January 24, 2024 (the “Original Term Sheet”) with the terms herein amending and superseding the terms set forth in the Amended and Restated Subscription Agreement (defined below), constitutes a binding commitment on the part of Meteora Capital LLC or any of its affiliates (“Meteora”, “Investor” or “Investors”) to arrange or provide financing to NKGen Biotech, Inc. (the “Company”) or any of its affiliates or any other person, which in return provides a binding commitment to, in collaboration with Meteora, mutually structure and receive such financing. This Term Sheet is binding and constitutes all material terms and is entered into in satisfaction of any definitive documentary requirements set forth on the Original Term Sheet.
